Embracer Group shuts down former Square Enix Montréal studio, just weeks after rebranding it as Onoma
Embracer Group is closing its down Square Enix Montréal studio - which it purchased as part of a $300m USD deal with Square Enix back in May - just weeks afterIn its Square Enix Montréal guise, Onama was a predominantly mobile-focused developer, perhaps best known for its Go series of puzzles games.
Onama's closure is said to be part of a larger cost-cutting initiative by Embracer Group, one that's reportedly also resulted in the cancellataion of a new Eidos-Montréal project - described as a Stranger-Things-inspired"kids on bikes" game in aA second unannounced IP in development at the studio is said to have been reduced in scope, while a new entry in the Deus Ex series is reportedly in the"very, very early" stages.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled TrialObjective: Binge-eating disorder, the most prevalent eating disorder, is a serious public health problem associated with obesity, psychiatric and medical comorbidities, and functional impairments. Binge-eating disorder remains underrecognized and infrequently treated, and few evidence-based treatments exist. The authors tested the effectiveness of naltrexone-bupropion and behavioral weight loss therapy (BWL), alone and combined, for binge-eating disorder comorbid with obesity. Methods: In a randomized double-blind placebo-controlled trial conducted from February 2017 to February 2021, using a 2×2 balanced factorial design, 136 patients with binge-eating disorder (81.6% women; mean age, 46.5 years; mean BMI, 37.1) were randomized to one of four 16-week treatments: placebo (N=34), naltrexone-bupropion (N=32), BWL+placebo (N=35), or BWL+naltrexone-bupropion (N=35). Overall, 81.7% of participants completed independent posttreatment assessments. Results: Intention-to-treat binge-eating remission rates were 17.7% in the placebo group, 31.3% in the naltrexone-bupropion group, 37.1% in the BWL+placebo group, and 57.1% in the BWL+naltrexone-bupropion group. Logistic regression of binge-eating remission revealed that BWL was significantly superior to no BWL, and that naltrexone-bupropion was significantly superior to placebo, but there was no significant interaction between BWL and medication. Mixed models of complementary measures of binge-eating frequency also indicated that BWL was significantly superior to no BWL. The rates of participants attaining 5% weight loss were 11.8% in the placebo group, 18.8% in the naltrexone-bupropion group, 31.4% in the BWL+placebo group, and 38.2% in the BWL+naltrexone-bupropion group. Logistic regression of 5% weight loss and mixed models of percent weight loss both revealed that BWL was significantly superior to no BWL. Mixed models revealed significantly greater improvements for BWL than no BWL on secondary measures (eating disorder psych
続きを読む »
Group With ‘Anti-Refugee Beliefs' Gathers Outside Kingston Hotel Sheltering MigrantsA group of over 20 people gathered at a hotel parking lot in Kingston, Massachusetts Sunday and “used a loud-speaker to express anti-refugee beliefs,” according to the town’s police department. The group was gathered outside the Baymont hotel, which is where over 100 migrants and homeless people are being housed, according to police. The group was dressed in matching tan…
続きを読む »
Jamelia gives birth to fourth child and tells fans 'I've got my own girl group'Jamelia, 41, who is the mother of daughters Teja, 21, Tiani, 17, and, True, four, has announced that she has given birth to her fourth girl after her announcing pregnancy in August
続きを読む »
Cranefly threat group uses innocent-looking info-stealerCranefly group unleashes nasty little technique using Microsoft Internet Information Services (IIS) logs
続きを読む »
Former Red Arrows Group Captain embarks on 3,200-mile Sahara Desert raceHe was diagnosed with incurable blood cancer in 2009
続きを読む »